In a paper written by David R. Kryder, Stanley P. Kowalski, and Anatole F. Krattiger, published in 2000, the researchers lay out a discussion on patent issues in regards to the implementation of Golden Rice in key countries. The authors’ research was funded by The Rockefeller Foundation and the fall under the institution of International Service for the Acquisition of Agri-biotech Applications (ISAA). Kryder, Kowalski and Krattiger were recruited to conduct a selective Freedom-To-Operate (FTO) analysis of Golden Rice. Their findings showed 43 patents which spanned the United States and the European Union. The patent problem is an issue because, what was supposed to be a free humanitarian effort to combat vitamin A deficiencies is actually a patent red tape nightmare.
The authors stress "The dominating consideration must be the impact of Golden Rice on the health and well being of rice producing and consuming populations" (ix).